Presentation19 Mar 2024 09:54
12/13 patients with positive response
1 patient dropped out early
Ultimate aim for Bex to become a cornerstone of cancer treatment
Phase 1 results as good as phase 2 from commercial point of view with such strong responses, almost certain a product will result from it reducing the risk for big pharma.